In the younger group, patients with MDS-R mutations had lower rates of CEBPA double mutations and CEBPA bZIP in-frame mutations but a higher rate of IDH2 and ETV6 mutations than those without MDS-R mutations. This evidence concerns the gene IDH2 and myelodysplastic syndrome.